General health and quality-of-life measures in active, recent, and comorbid mental disorders: a population-based health 2000 study

Comprehensive Psychiatry

Volumn 50, Issue 2, 2009, Pages 108-114

  Pirkola, Sami ^a,b   Saarni, Samuli ^b   Suvisaari, Jaana ^b   Elovainio, Marko ^b   Partonen, Timo ^b   Aalto, Anna Mari ^b   Honkonen, Teija ^d   Perälä, Jonna ^b   Lönnqvist, Jouko ^b,c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEMALE; FINLAND; HEALTH STATUS; HEALTH SURVEYS; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 59649107961     PISSN: 0010440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.comppsych.2008.06.003     Document Type: Article

References (47)

1. Murray C.J., and Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 349 9064 (1997) 1498-1504
2. Kessler R.C., McGonagle K.A., Zhao S., et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51 1 (1994) 8-19
3. Regier D.A., Narrow W.E., and Rae D.S. The epidemiology of anxiety disorders: the Epidemiologic Catchment Area (ECA) experience. J Psychiatr Res 24 Suppl 2 (1990) 3-14
4. Regier D.A., Farmer M.E., Rae D.S., et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264 19 (1990) 2511-2518
5. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., and Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62 6 (2005) 593-602
6. Zimmerman M., Chelminski I., and Zisook S. Recognition and treatment of depression with or without comorbid anxiety disorders. CNS Spectr 11 1 Suppl 1 (2006) 1-16
7. Zimmerman M., Rothschild L., and Chelminski I. The prevalence of DSM-IV personality disorders in psychiatric outpatients. Am J Psychiatry 162 10 (2005) 1911-1918
8. Weiss R.D., Ostacher M.J., Otto M.W., et al. Does recovery from substance use disorder matter in patients with bipolar disorder?. J Clin Psychiatry 66 6 (2005) 730-735 [quiz 808-9]
9. Bruce S.E., Yonkers K.A., Otto M.W., et al. Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry 162 6 (2005) 1179-1187
10. Kessler R.C., Nelson C.B., McGonagle K.A., Edlund M.J., Frank R.G., and Leaf P.J. The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Orthop 66 1 (1996) 17-31
11. Mojtabai R., Olfson M., and Mechanic D. Perceived need and help-seeking in adults with mood, anxiety, or substance use disorders. Arch Gen Psychiatry 59 1 (2002) 77-84
12. Carpiniello B., Baita A., Carta M.G., et al. Clinical and psychosocial outcome of patients affected by panic disorder with or without agoraphobia: results from a naturalistic follow-up study. Eur Psychiatry 17 7 (2002) 394-398
13. Lowe B., Unutzer J., Callahan C.M., Perkins A.J., and Kroenke K. Monitoring depression treatment outcomes with the patient health questionnaire-9. Med Care 42 12 (2004) 1194-1201
14. Ormel J., Oldehinkel A.J., Nolen W.A., and Vollebergh W. Psychosocial disability before, during, and after a major depressive episode: a 3-wave population-based study of state, scar, and trait effects. Arch Gen Psychiatry 61 4 (2004) 387-392
15. Malyszczak K., and Pawlowski T. Distress and functioning in mixed anxiety and depressive disorder. Psychiatry Clin Neurosci 60 2 (2006) 168-173
16. Beck A.T., Steer R.A., and Garbin M.G. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 8 (1988) 77-100
17. Goldberg D.P., Gater R., Sartorius N., et al. The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychol Med 27 1 (1997) 191-197
18. Steer R.A., Beck A.T., Riskind J.H., and Brown G. Differentiation of depressive disorders from generalized anxiety by the Beck Depression Inventory. J Clin Psychol 42 3 (1986) 475-478
19. Tengs T.O., and Wallace A. One thousand health-related quality-of-life estimates. Med Care 38 6 (2000) 583-637
20. Rubin R.R., and Peyrot M. Quality of life and diabetes. Diabetes Metab Res Rev 15 3 (1999) 205-218
21. Wandell P.E. Quality of life of patients with diabetes mellitus. An overview of research in primary health care in the Nordic countries. Scand J Prim Health Care 23 2 (2005) 68-74
22. Bradley C., and Speight J. Patient perceptions of diabetes and diabetes therapy: assessing quality of life. Diabetes Metab Res Rev 18 Suppl 3 (2002) S64-S69
23. Stumvoll M., Goldstein B.J., and van Haeften T.W. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365 9467 (2005) 1333-1346
24. Pirkola S., Isometsä E., Suvisaari J., et al. DSM-IV mood-, anxiety- and alcohol use disorders and their comorbidity in the Finnish general population. Results from the Health 2000 Study. Soc Psychiatry Psychiatr Epidemiol 40 1 (2005) 1-10
25. Aromaa A., and Koskinen S.E. Health and functional capacity in Finland. Baseline results of the Health 2000 Health Examination Survey (2004), Hakapaino Oy, Helsinki
26. Pirkola S.P., Poikolainen K., and Lonnqvist J.K. Currently active and remitted alcohol dependence in a nationwide adult general population-results from the Finnish Health 2000 Study. Alcohol Alcohol 41 3 (2006) 315-320
27. Goldberg D.P., Rickels K., Downing R., and Hesbacher P. A comparison of two psychiatric screening tests. Br J Psychiatry 129 (1976) 61-67
28. EuroQol-a new facility for the measurement of health-related quality of life. The EuroQoL Group. Health Policy 16 3 (1990) 199-208
29. Brooks R. EuroQol: the current state of play. Health Policy 37 1 (1996) 53-72
30. Rabin R., and de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 33 (2001) 337-340 [may]
31. Sintonen H. The 15D measure of health related quality of life: reliability, validity and sensitivity of its health state descriptive system. Working paper 41 (1994), Centre for Health Program Evaluation, Monash University, Melbourne
32. Sintonen H. The 15D measure of health related quality of life. II Feasibility, reliability and validity of its valuation system. Working paper 42 (1995), Centre for Health Program Evaluation, Monash University, Melbourne
33. Sintonen H. The 15D instrument of health-related quality of life: properties and applications. Ann Med 33 (2001) 328-336 [may]
34. Saarni S.I., Harkanen T., Sintonen H., et al. The impact of 29 chronic conditions on health-related quality of life: a general population survey in Finland using 15D and EQ-5D. Qual Life Res 15 8 (2006) 1403-1414
35. Dolan P., Gudex C., Kind P., and Williams A. The time trade-off method: results from a general population study. Health Econ 5 2 (1996) 141-154
36. Pirkola S., Isometsa E., Aro H., et al. Childhood adversities as risk factors for adult mental disorders. Soc Psychiatry Psychiatr Epidemiol 40 (2005) 769-777
37. Puavilai G., Chanprasertyotin S., and Sriphrapradaeng A. Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (ADA), 1998 WHO consultation criteria, and 1985 WHO criteria. World Health Organization. Diabetes Res Clin Pract 44 1 (1999) 21-26
38. WORLD HEALTH ORGANIZATION EXPERT COMMITTEE: Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation, part 1: diagnosis and classification of diabetes mellitus; 1999.
39. Tobin J. Estimation of relationships for limited dependent variables. Econometrica 26 (1958) 24-36
40. Cong R. Marginal effects for the tobit model; 2000.
41. Saarni S., Suvisaari J., Sintonen H., Koskinen S., Härkänen T., and Lönnqvist J. The health-related quality of life impact of chronic conditions varied with age in general population. J Clin Epidemiol 60 (2007) 1288-1297
42. Wittchen H.U., Hofler M., and Merikangas K. Toward the identification of core psychopathological processes?. Arch Gen Psychiatry 56 10 (1999) 929-931
43. Krueger R.F. The structure of common mental disorders. Arch Gen Psychiatry 56 10 (1999) 921-926
44. Wittchen H.U., Schuster P., and Lieb R. Comorbidity and mixed anxiety-depressive disorder: clinical curiosity or pathophysiological need?. Hum Psychopharmacol 16 S1 (2001) S21-S30
45. Moussavi S., Chatterji S., Verdes E., Tandon A., Patel V., and Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 370 9590 (2007) 851-858
46. Moffitt T.E., Harrington H., Caspi A., et al. Depression and generalized anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years. Arch Gen Psychiatry 64 6 (2007) 651-660
47. Saarni S.I., Suvisaari J., Sintonen H., et al. Impact of psychiatric disorders on health-related quality of life: a general population survey. Br J Psychiatry (2007) 190